MUC-1-specific autologous T cells, isolated from patient peripheral blood mononuclear cells (PBMCs), were expanded by incubation with a MUC-1-presenting cell line prior to administration to pancreatic cancer patients. This evidence concerns the gene MUC1 and pancreatic neoplasm.